Yes, absinthe is legal in Japan, but its sale and production are tightly controlled under the Pharmaceuticals and Medical Devices Act (PMDA) and the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. While thujone-free absinthe is permitted, products exceeding 10 mg/kg thujone face prohibition, aligning with 2023 PMDA enforcement guidelines.
Key Regulations for Absinthe in Japan
- Thujone Limit: Absinthe containing more than 10 mg/kg of thujone is classified as a restricted pharmaceutical under the PMDA, requiring special licensing for import or sale.
- Licensing Requirements: Distributors must obtain a “Specified Pharmaceuticals Dealer” license from the Ministry of Health, Labour and Welfare (MHLW), with inspections verifying thujone content.
- 2026 Compliance Shift: From April 2026, the MHLW will enforce stricter labeling standards, mandating explicit thujone content disclosure and origin certification for all absinthe imports.
Local enforcement prioritizes counterfeit detection, particularly for European brands mislabeled as “traditional absinthe.” Retailers violating thujone thresholds face fines up to ¥3 million ($20,000) or imprisonment under the PMDA. Consumers should verify third-party lab reports before purchase, as uncertified products may be seized at customs.